SIGA TECHNOLOGIES INC (SIGA)
About SIGA TECHNOLOGIES INC
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $94.6M
- Net income
- $23.3M
- Total assets
- $219.5M
- Market cap
- $308.4M
- Gross margin
- 68.6%
- Operating margin
- 25.1%
- Net margin
- 24.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $94.6M
- Cost of revenue
- $29.7M
- Gross profit
- $64.9M
- Operating expenses
- $41.2M
- Operating income
- $23.7M
- Income tax
- $7.1M
- Net income
- $23.3M
- EPS (basic)
- $0.33
- EPS (diluted)
- $0.32
Balance sheet
- Total assets
- $219.5M
- Current assets
- $212.9M
- Total liabilities
- $20.6M
- Current liabilities
- $18.0M
- Shareholders’ equity
- $198.8M
Cash flow
- Operating cash flow
- $43.5M
- Investing cash flow
- -$355.0K
- Financing cash flow
- -$43.6M
- Net cash flow
- -$433.8K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $308.4M
- P/E ratio
- 9.7
- EPS (diluted)
- $0.32
- Dividend yield
- 19.29%
- Shares outstanding
- 99.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 9, 1997
Siga Technologies Inc (SIGA) Stock Price
- Profitable — net income of $23.3M in FY2025.
- Revenue declined 29% from FY2021 to FY2025.
- Gross margin of 68.6%, net margin 24.6%.
- Trading 67% below its 52-week high.
- Pays a dividend yielding about 19.29% annually.
- Valued at a price-to-earnings (P/E) ratio of 9.7.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review SIGA TECHNOLOGIES INC.
Write a review
News about SIGA TECHNOLOGIES INC
News & sentiment via Polygon.io
Siga Technologies Inc: frequently asked questions
Is Siga Technologies Inc an American company?
Siga Technologies Inc is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Siga Technologies Inc headquartered?
Siga Technologies Inc is headquartered in New York, New York, United States.
Is Siga Technologies Inc publicly traded?
Yes — Siga Technologies Inc is a publicly traded company. Its stock trades under the ticker symbol SIGA on the NASDAQ.
What does Siga Technologies Inc do?
Siga Technologies Inc is an American Pharmaceuticals company in the Health & Beauty sector.
